89bio, Inc.
ETNBNASDAQHealthcare
$14.84
+$0.00(+0.00%)
Market Cap$2.2B
P/E Ratio—
52W High$15.06
52W Low$4.16
89bio, Inc. (ETNB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ETNB · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.35B | $0.12B | $0.08B | $0.07B | $0.04B |
| G&A Expenses | $0.04B | $0.03B | $0.02B | $0.02B | $0.01B |
| Total Operating Expenses | $0.38B | $0.15B | $0.10B | $0.09B | $0.05B |
| Operating Income | ($0.38B) | ($0.15B) | $0.10B | ($0.09B) | ($0.05B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.37B) | ($0.14B) | ($0.10B) | ($0.09B) | ($0.05B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Net Income | ($0.37B) | ($0.14B) | ($0.10B) | ($0.09B) | ($0.05B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.51 | $-2.00 | $-2.93 | $-4.48 | $-3.08 |
| Wtd Avg Shares | 0.10B | 0.07B | 0.03B | 0.02B | 0.02B |
| EBITDA | ($0.38B) | ($0.13B) | ($0.10B) | ($0.09B) | ($0.05B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more 89bio, Inc. data
About 89bio, Inc. (ETNB) Income Statement
89bio, Inc. (ETNB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, ETNB reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.37B) — a net profit margin of —.
Frequently asked questions
ETNB · 4 questions89bio, Inc. (ETNB) reported revenue of $0.00B for 2024, down —% year-over-year.
ETNB revenueETNB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08